1. Home
  2. ZYME vs ARCO Comparison

ZYME vs ARCO Comparison

Compare ZYME & ARCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zymeworks Inc.

ZYME

Zymeworks Inc.

HOLD

Current Price

$23.40

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo Arcos Dorados Holdings Inc. Shares

ARCO

Arcos Dorados Holdings Inc. Shares

HOLD

Current Price

$7.66

Market Cap

1.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZYME
ARCO
Founded
2003
2007
Country
United States
Uruguay
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.8B
IPO Year
2022
2011

Fundamental Metrics

Financial Performance
Metric
ZYME
ARCO
Price
$23.40
$7.66
Analyst Decision
Strong Buy
Hold
Analyst Count
11
2
Target Price
$38.90
$8.60
AVG Volume (30 Days)
649.0K
1.2M
Earning Date
03-02-2026
03-19-2026
Dividend Yield
N/A
3.13%
EPS Growth
33.33
N/A
EPS
N/A
N/A
Revenue
$105,965,000.00
N/A
Revenue This Year
$162.82
$11.64
Revenue Next Year
N/A
$6.59
P/E Ratio
N/A
$7.26
Revenue Growth
38.87
N/A
52 Week Low
$9.03
$6.51
52 Week High
$28.49
$8.98

Technical Indicators

Market Signals
Indicator
ZYME
ARCO
Relative Strength Index (RSI) 47.53 36.17
Support Level $22.28 $7.04
Resistance Level $23.66 $7.73
Average True Range (ATR) 1.36 0.26
MACD -0.08 -0.08
Stochastic Oscillator 16.70 15.00

Price Performance

Historical Comparison
ZYME
ARCO

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

About ARCO Arcos Dorados Holdings Inc. Shares

Arcos Dorados Holdings Inc operates McDonald's branded restaurants in various countries and territories in Latin America and the Caribbean. The Company manages its business as distinct geographic segments and its operations are divided into three geographic divisions, as follows: Brazil, the North Latin American division, or NOLAD, which is comprised of Costa Rica, Mexico, Panama, Puerto Rico, Martinique, Guadeloupe, French Guiana and the U.S. Virgin Islands of St. Croix and St. Thomas and the South Latin American division, or SLAD, which is comprised of Argentina, Chile, Ecuador, Peru, Uruguay, Colombia, Venezuela, Trinidad and Tobago, Aruba and Curacao. Their menu includes hamburgers, McNuggets, salad, sandwiches, French fries, and others.

Share on Social Networks: